NEWPORT BEACH, CA--(Marketwired - Mar 22, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is introducing a new line of premium concentrate-infused products that it will make available through its existing business partners, before kicking off a new marketing campaign. Advantis CEO, Christopher Swartz will comment further on this product line along with providing a future outlook and shareholder update on Small Cap Voice next week.
"This is a luxury-inspired, premium quality, vacuum concentrate-infused cannabis amalgamation that is more powerful than anything we've seen in the marketplace," Advantis CEO, Christopher Swartz, said. "Our current clients and partners, like our friends at Speedweed, are excited about supplying this more concentrated version of medicine to their member-patients. We are in negotiations with some to expand our product exposure to hundreds of new cooperatives around the state." Swartz hinted at some of the features of the new product line. "Several different exotic flavor profiles of some of the most potent medicine you may ever have, including strawberry, coconut and others," Swartz added.
Swartz says that the company has been in negotiations with several companies that have shown great interest in the direction Advantis is going in. "We are proactively responding to the growing demand for innovative, premium quality products. Concentrates, vapes, oils, rosin presses, premium pre-rolled, and of course packaging; We are at the forefront of innovative solutions and supply only the most sought after products." Advantis partners with cultivators, dispensaries and other cooperative based organizations to co-brand products and deliver developed shared and/or proprietary products to its client base. "This new line of products is just the tip of the iceberg," Swartz projected, "and with our current business process we can hypothetically introduce almost any premium in-demand product and have a ready market for it."
Next week, Swartz will be interviewed by Small Cap Voice's, Stuart Smith. Swartz says he is excited to answer shareholder questions and provide some insight into the company business. "Shareholders can fill out the questionnaire on our website, and I will answer some of the more popular asked questions," Swartz said. "I am so proud of the work we are doing here; I want to share with our shareholders the story of how we got here and what the amazing future holds for Advantis." Swartz says shareholders can ask questions before the interview next week. He added that the company will announce its sponsorship of a podcast in the near future. The interview will be posted on the Advantis company website after it concludes.
Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com
Follow us on Social Media Facebook Instagram Twitter
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under eitherAct.